Quarterly report pursuant to Section 13 or 15(d)

Expense Reimbursement Agreement (Details)

v3.19.3
Expense Reimbursement Agreement (Details) - USD ($)
1 Months Ended 9 Months Ended
Mar. 15, 2019
Apr. 10, 2019
Sep. 30, 2019
Sep. 30, 2018
Expense Reimbursement Agreement (Textual)        
Related party transaction, description   The loans are interest-free and can be pre-paid at any time without penalty, but are required to be paid back (subject to a customary waiver against the Company’s Trust Account) upon the earlier of (i) the closing of the Transaction, (ii) the consummation by the Company of a transaction with a third party constituting the Company’s initial Business Combination, or (iii) the liquidation of the Company if it does not consummate an initial Business Combination prior to its deadline to do so (a “Liquidation”). Promptly after signing the Term Sheet, the Company received the loan of $400,000 to fund the Operating Expenses.    
Expense due under reimbursement agreement     $ 254,359
Promissory Note [Member]        
Expense Reimbursement Agreement (Textual)        
Related party transaction, description (i) the consummation of a Business Combination or (ii) the liquidation of the Company. Up to $1,000,000 of the loans under the March Promissory Note may be converted, at the Sponsor's discretion, into units of the post-Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Units.      
Expense due under reimbursement agreement     $ 254,359  
KBL Healthcare Management, LLC [Member] | Sponsor [Member]        
Expense Reimbursement Agreement (Textual)        
Related party transaction, description (i) the consummation of a Business Combination or (ii) the Company's liquidation. Under the Expense Reimbursement Agreement, the Company will reimburse the Sponsor for the compensation expense incurred by KBL Management for its employee in the amount of $180,000 per year plus health insurance costs of $1,139 per month.